ArticleAdvances in radiation oncology
Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center.
Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Proton Therapy Utilization Among Adult Cancer Patients.International journal of particle therapy · 2026Article
- Association of ZIP code sociodemographic characteristics with radiation oncology services, payments, and technique utilization.Frontiers in oncology · 2026Article
- Utilizing proton therapy to reduce health-care disparities among patients with breast cancers.JNCI cancer spectrum · 2025Article
- Health Disparities and Inequities in the Utilization of Proton Therapy for Prostate Cancer.Cancers · 2024Review
- Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment.JAMA network open · 2024Article
- Article
- Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review.International journal of particle therapy · 2023Review
- Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.International journal of particle therapy · 2023Article
- Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.JAMA network open · 2022Article
- Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date.International journal of particle therapy · 2021Article
- Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14).International journal of particle therapy · 2019Article
- Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review.Advances in radiation oncologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeDespite increasing use, proton therapy (PT) remains a relatively limited resource. The purpose of this study was to assess clinical and demographic differences in PT use for prostate cancer compared to intensity modulated radiation therapy (IMRT) at a single institution. METHODS AND MATERIALS: All patients with low- and intermediate-risk prostate cancer (N = 633) who underwent definitive radiation therapy between 2010 and 2015 were divided into PT (n = 508) and IMRT (n = 125) comparison groups and compared using χ
resultsThe PT and IMRT cohorts varied by age, race, poverty, distance, treatment year, and treating physician. Patients who underwent IMRT were more likely to be older (mean age, 66 vs. 68 years), black (51% vs. 75%), and living in poverty or close to the facility (mean distance between residence and facility, 90 vs. 21 miles;
conclusionSociodemographic disparities exist in PT use for prostate cancer at an urban academic institution. Further investigation of potential barriers to access is warranted to ensure equitable distribution across all demographic groups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.